Lloyds Banking Group’s ARYX THERAPEUTICS INC COM STK (DE) ARYX Stock Holding History
Bought
Maintained
Sold
Lloyds Banking Group's ARYX Position: Q4 2013 in Review
Lloyds Banking Group sold out of ARYX THERAPEUTICS INC COM STK (DE) (ARYX) in Q4 2013, closing a stake of 520,142 shares.
Lloyds Banking Group first reported a position in ARYX in Q3 2013 and held it in 1 quarter. The position peaked at $0 in Q3 2013. 0 funds tracked by Wall St. Rank hold ARYX as of Q4 2013.
- Lloyds Banking Group reported no remaining ARYX THERAPEUTICS INC COM STK (DE) position as of Q4 2013 after selling out during the quarter.
- Lloyds Banking Group sold 520,142 ARYX THERAPEUTICS INC COM STK (DE) shares in Q4 2013.
- Lloyds Banking Group first reported a position in ARYX THERAPEUTICS INC COM STK (DE) in Q3 2013 and held it in 1 quarter.
- Lloyds Banking Group's ARYX THERAPEUTICS INC COM STK (DE) position peaked at $0 in Q3 2013.
- 0 funds tracked by Wall St. Rank held ARYX THERAPEUTICS INC COM STK (DE) as of Q4 2013.
Based on Lloyds Banking Group's 13F filing for Q4 2013, filed 10 Feb 2014.